The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / EULAR 2015: Role of ACPA Positivity in Osteoarthritis

EULAR 2015: Role of ACPA Positivity in Osteoarthritis

September 15, 2015 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Colored X-ray of the knee of a patient with OA. Patients who test positive for anti-citrullinated protein antibodies show signs of bone erosion before they have clinical signs of arthritis.

Colored X-ray of the knee of a patient with OA. Patients who test positive for anti-citrullinated protein antibodies show signs of bone erosion before they have clinical signs of arthritis.
Image Credit: Scott Camazine/sciencesource.com

ROME, Italy—The role of ACPA positivity in osteoarthritis is coming more into focus, with results from recent studies by researchers in Germany showing that ACPA positivity apparently works in concert with rheumatoid factor positivity to enhance bone erosion and that ACPA-positive patients show signs of bone erosion before they have clinical signs of arthritis.

You Might Also Like
  • EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
  • ACPA-Positive & ACPA-Negative Patients with RA: The Difference Begins in the Lungs
  • EULAR 2015: Imaging in Rheumatology
Explore This Issue
September 2015
Also By This Author
  • 2015 ACR/ARHP Annual Meeting: How Gender Differences Affect Pain

The findings were presented at a session during EULAR 2015, the annual congress of the European League Against Rheumatism (EULAR).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Stephanie Finzel, MD, a resident in the rheumatology department at the University of Erlangen and a researcher on several recent studies on the topic, said these latest findings underline the importance of testing for anti-citrullinated protein antibodies (ACPA) positivity.

ACPAs & RF

In one study, the metacarpophalangeal joints (MCPJs) of 242 patients were scanned using high-resolution peripheral quantitative computed tomography (HR-pQCT). Then the number of erosions and their sizes were evaluated in 238 of them.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A total of 112 patients showed positivity for both ACPAs and rheumatoid factor (RF), 28 were positive only for RF, 29 only for ACPAs and 29 for neither. The number of erosions and their sizes were highest in those both ACPA and RF positive, and the differences were significant in erosion number compared with those who were negative for both (p=0.001) and significant for erosion size compared with those who were ACPA negative (p<0.001).

They also found that RF influenced erosion number and size in patients who were ACPA positive, but not in ACPA-negative patients.

Researchers at the university also scanned the MCPJ of 10 people who were positive for ACPA, but with no signs of arthritis, with HR-pQCT. Ten healthy controls were also scanned, and the results for bone mineral density, cortical thickness and trabecularity were compared.2

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The findings showed that it’s possible, with HR-pQCT, to measure bone changes in ACPA-positive patients without clinical signs of RA. Alterations were seen—mainly cortical thinning and fenestration in the cortical area.

Dr. Finzel said they support the idea that bone changes in RA are probably not due exclusively to inflammation and synovitis, but “occur in the phase of breakdown of immune tolerance” and ACPAs have the potential to be pathogenic.

“Bone in early rheumatoid arthritis likely undergoes vehement changes already in the very first weeks after the onset of swelling and pain,” she said. “Highly sensitive diagnostic tools, such as HR-pQCT, MRI or musculoskeletal ultrasound, are required to be able to diagnose correctly and treat early.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Osteoarthritis Tagged With: ACPA, Immunology, OA, Osteoarthritis, patient care, TreatmentIssue: September 2015

You Might Also Like:
  • EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
  • ACPA-Positive & ACPA-Negative Patients with RA: The Difference Begins in the Lungs
  • EULAR 2015: Imaging in Rheumatology
  • EULAR 2015: Problems with Biomarkers

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)